Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02080832 · ClinicalTrials.gov registry record · Phase 2
Brain Function and Structure in Cocaine Dependence
A Phase 2 study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- Phase 2
- Development phase
- 54
- Enrollment target
NCT02080832 is a Phase 2 study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 54 participants.
The verdict
NCT02080832, a Phase 2 study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 54 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the role of brain MRI findings in predicting treatment outcomes among individuals with cocaine dependence.
Interventions
- DRUG Placebo
- DRUG Citalopram
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2010-02 |
| Est. Completion | 2016-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02080832
The ClinicalTrials.gov registry entry for NCT02080832 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02080832 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02080832 about?
NCT02080832 is a clinical study titled "Brain Function and Structure in Cocaine Dependence". The purpose of this study is to examine the role of brain MRI findings in predicting treatment outcomes among individuals with cocaine dependence.
What is the current status of trial NCT02080832?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 54 participants. The study started on 2010-02. Estimated completion is 2016-02.
What interventions are being tested in trial NCT02080832?
The interventions under investigation include: Placebo (DRUG), Citalopram (DRUG).
Who is sponsoring clinical trial NCT02080832?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.